Medi Whale

Home / Medi Whale

Medi Whale Inc. announced on the last 18th that it signed an MOU with Sankara Nethralaya Chennai Eye Hospital. Under this agreement, they will proceed with a prospective study about eye disease classification and cardiovascular risk factor prediction through three institutions in India. Sankara Nethralaya Chennai Eye Hospital is a large hospital with over 90
Medi Whale Inc. got a tech transfer from Yonsei Medical Center on the last 22nd. The transfer covers 8 patents relevant to Medi Whale’s heart diagnosis AI via eye exam. Since March of the last year, Medi Whale has been developing an AI solution of the eye and vascular diseases detection through eye image analysis.
On the last 17th, Medi Whale Inc. and Siloam Eye Hospital signed an MOU for enhancement of AI fundus screening device. Both sides agreed that their partnership would help the automatic fundus screening device to be successfully adapted in a clinical environment, not limited under the academic field. They are planning to reach a more
On last 14th of December, Medi Whale Inc. opened an all-in-one eye disease auto-diagnostic device, in which artificial intelligence software and fundus camera are combined together. This medical healthcare startup, which develops a diagnosis system based on fundus photography, displayed the combined device during the Asian Pacific Vitreo-Retina Society(APVRS) 2018. Last September, Medi Whale started developing the auto-diagnostic
Medi Whale Inc. announced on last 4th December that they are now starting the sales of ‘DrNoon’, a diagnostic solution of eye diseases using artificial intelligence(AI). They said that they have recently established a business headquarter in Singapore to support the sales in Southeast Asia. They are now supplementing their manpower for sales for hospitals
A new technology that enables a diagnosis of cardiovascular diseases only through eye images was first opened. The vessels in eyes which reflect the overall body condition enables to expect risks of a range of diseases. Early this year, Verily have suggested a possibility of expecting basic biomarkers including age, blood pressure, and smoking preference
On last 25th October, a Korea-Indonesia Tech Startup Demo day took a place in Jakarta. Organized by Korean small and medium Business Corporation(SBC), Korean International Trade Association(KITA), Korea Creative Contents Agency(KOCCA), and Indonesian Agency for Creative Economy(BEKRAF), 25 startups from Korea and Indonesia have made their pitch for about 100 potential investors. Medi Whale Inc.
Medi Whale Inc., a healthcare startup based in South Korea, has made a pitch introducing its technology in Tech in Asia 2018 Arena pitch battle as one of the six selected finalists. Arena pitch battle is a startup competition annually held at Tech In Asia conference. This year, six startups from Indonesia, Vietnam, South Korea,
On last July 7th, in APTOS 2018 Singapore, Dr. Rim gave a presentation about his research, “Retinal Damage as the Window to Cardiovascular Organ Damage: Use of Big Data & Machine Learning”. Dr. Rim, one of the co-founders of Medi-Whale Inc., is engaged in Yonsei University College of Medicine as a professor and ophthalmologist in
Medi-Whale Co. sponsored the 3RD Asia Pacific Tele-Ophthalmology Symposium (APTOS) held in Singapore. In their exhibition booth the ‘Dr. Noon’, Medi-Whale’s product, was displayed on July 7-8, 2018.  APTOS was founded by tele-ophthalmologists in Asia-Pacific region in May 2016, aggregating professional researchers, technicians, and clinicians to share, collaborate, exchange individual perspectives, knowledge or ideas. Along
Medi Whale Co. signed a side agreement of ‘Dr. Noon’ demonstration agreement with Khanty-Mansiysk Hospital (Russia). Last December of 2017, Medi Whale have signed an agreement with Khanty-Mansiysk District for appliance of AI eye examination software based on deep learning artificial intelligence. The agreement of this December is a side agreement of the previous agreement,
Medi Whale and its product, Dr. Noon, was introduced to media by the Korea Economic Daily. The article is based on interview of Choi, the CEO of Medi Whale. Choi said that their program Dr. Noon can “diagnose disease risk of cardiovascular, macular, and optic nerve with 95% reliability by analyzing the fundus image”. The